Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eunhyun D. Kim"'
Autor:
Ayat Zagzoog, Asher L. Brandt, Tallan Black, Eunhyun D. Kim, Riley Burkart, Mikin Patel, Zhiyun Jin, Maria Nikolaeva, Robert B. Laprairie
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Abstract The first synthetic cannabinoid receptor agonists (SCRAs) were designed as tool compounds to study the endocannabinoid system’s two predominant cannabinoid receptors, CB1R and CB2R. Unfortunately, novel SCRAs now represent the most rapidly
Externí odkaz:
https://doaj.org/article/b6aa1fa4ea2b4839a0bdba526e98a3e7
Autor:
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, Eunhyun D. Kim, Connor S. Frank, Tallan Black, Pramodkumar D. Jadhav, Larry A. Holbrook, Robert B. Laprairie
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract The Cannabis sativa plant contains more than 120 cannabinoids. With the exceptions of ∆9-tetrahydrocannabinol (∆9-THC) and cannabidiol (CBD), comparatively little is known about the pharmacology of the less-abundant plant-derived (phyto)
Externí odkaz:
https://doaj.org/article/a52077388f3b4632a837de46a8b03235
Autor:
Tallan Black, Robert B. Laprairie, Asher L. Brandt, Zhiyun Jin, Maria Nikolaeva, Riley Burkart, Ayat Zagzoog, Mikin Patel, Eunhyun D. Kim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Scientific Reports
Scientific Reports
The first synthetic cannabinoid receptor agonists (SCRAs) were designed as tool compounds to study the endocannabinoid system’s two predominant cannabinoid receptors, CB1R and CB2R. Unfortunately, novel SCRAs now represent the most rapidly prolifer
Autor:
Eunhyun D. Kim, Pramodkumar D. Jadhav, Kawthar A. Mohamed, Connor Frank, Tallan Black, Ayat Zagzoog, Larry A. Holbrook, Robert B. Laprairie, Hye Ji J. Kim
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
The Cannabis sativa plant contains more than 120 cannabinoids. With the exceptions of ∆9-tetrahydrocannabinol (∆9-THC) and cannabidiol (CBD), comparatively little is known about the pharmacology of the less-abundant plant-derived (phyto) cannabin